r.serrano
TL2 Moderator · Osijek
Contributes reviews on supplier material. Based in Osijek.
Joined 13 February 2025 · last posted 12h
80 posts, newest first. Showing up to 150.
-
A promotion I argued against, and why I lost — a second dataset Replied, post #8 · Documentation › Doc review · 27 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Seven-day rolling means and why weekly readings mislead Replied, post #97 · Outcomes › Progress reports · 24 Jul 2026 · 0 likes This follows post #94 rather than contradicting it. Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale.…
-
Distinguishing a red flag from an inconvenience — a second dataset Replied, post #4 · Sourcing › Red flags · 19 Jul 2026 · 28 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #76 · Analytics › Home & field testing · 19 Jul 2026 · 21 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #8 · Clinical › Bloodwork · 17 Jul 2026 · 12 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #90 · Analytics › Home & field testing · 16 Jul 2026 · 2 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Historical amylin analogues and what happened to them Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 13 Jul 2026 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #19 · Analytics › Mass spectrometry · 12 Jul 2026 · 21 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #143 · Practice › Interactions · 9 Jul 2026 · 2 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
How to ask a question when you cannot say why you are asking it Replied, post #27 · Start Here › How to Ask · 1 Jul 2026 · 0 likes This follows post #24 rather than contradicting it. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #77 · Devices › Syringes & needles · 19 Jun 2026 · 0 likes This follows post #74 rather than contradicting it. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses.…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #3 · Compounds › Retatrutide · 11 Jun 2026 · 0 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #20 · Practice › Reconstitution · 11 Jun 2026 · 2 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Replied, post #2 · Devices › Pens & autoinjectors · 7 Jun 2026 · 15 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
Revisiting: The best-written scientific paper you have read Replied, post #18 · Lounge › Off topic · 6 Jun 2026 · 0 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #19 · Evidence › Meta-analyses · 2 Jun 2026 · 22 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #15 · Pharmacology › Pharmacokinetics · 1 Jun 2026 · 29 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #30 · Compounds › Repair & healing peptides · 23 May 2026 · 6 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #22 · Practice › Storage & stability · 10 May 2026 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Time to steady state after a dose increase Replied, post #50 · Pharmacology › Pharmacokinetics · 10 May 2026 · 25 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #42 · Evidence › Journal club · 4 May 2026 · 18 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #112 · Practice › Reconstitution · 25 Apr 2026 · 29 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Follow-up: Sleep quality changes during weight loss Replied, post #10 · Wellbeing › Sleep · 25 Apr 2026 · 13 likes Coming back to post #8, because the follow-up matters more than the original answer. Gastrointestinal effects overnight: nausea or reflux or constipation at night can…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #24 · Practice › Reconstitution · 24 Apr 2026 · 23 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
List price versus negotiated price versus what you pay Replied, post #83 · Access › Pricing · 15 Apr 2026 · 31 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #15 · Data & Tools › Calculators · 2 Apr 2026 · 25 likes This follows post #12 rather than contradicting it. Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat:…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #47 · Practice › Reconstitution · 18 Mar 2026 · 28 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #26 · Lounge › Introductions · 10 Mar 2026 · 0 likes Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let you know they are glad you are here.
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #3 · Clinical › Comorbidities · 1 Mar 2026 · 3 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #79 · Practice › Storage & stability · 24 Feb 2026 · 0 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #36 · Analytics › Mass spectrometry · 13 Feb 2026 · 4 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
Trifluoroacetate content and its consequences Replied, post #83 · Analytics › Impurities & related substances · 4 Feb 2026 · 25 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Waist circumference technique and its repeatability Replied, post #47 · Outcomes › Progress reports · 4 Feb 2026 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #60 · Sourcing › Vendor reports · 21 Jan 2026 · 1 like Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
What to include when your question involves a chromatogram Replied, post #34 · Start Here › How to Ask · 10 Jan 2026 · 13 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
The headache that turns out to be dehydration Replied, post #111 · Nutrition & Training › Hydration & electrolytes · 26 Dec 2025 · 0 likes Coming back to post #109, because the follow-up matters more than the original answer. Constipation and hydration: dehydration makes constipation worse. Increasing…
-
Reading SURMOUNT-1 without the press release Replied, post #93 · Compounds › Tirzepatide · 8 Dec 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #11 · Compounds › Retatrutide · 25 Nov 2025 · 0 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Request: export my own posts — one year on Replied, post #15 · Meta › Feature requests · 24 Nov 2025 · 0 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
-
Reading SURMOUNT-1 without the press release Replied, post #72 · Compounds › Tirzepatide · 20 Nov 2025 · 6 likes post #71 is right about the mechanism and I think understates the practical bit. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
-
Availability by country, dated, with primary sources Replied, post #55 · Access › International · 11 Nov 2025 · 23 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Thyroid function tests during substantial weight change Replied, post #129 · Clinical › Bloodwork · 10 Nov 2025 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The headache that turns out to be dehydration Replied, post #37 · Nutrition & Training › Hydration & electrolytes · 28 Oct 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Substitution between formats during a shortage Replied, post #80 · Access › Shortages · 22 Oct 2025 · 0 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Payment mechanics and the recovery options that do not exist Replied, post #80 · Sourcing › Payments · 22 Oct 2025 · 0 likes Escrow services: some third-party services hold payment until the buyer confirms receipt. They add cost but reduce risk if the supplier is unknown.
-
When to stop reading forums, including this one Replied, post #31 · Wellbeing › Mental health · 30 Sep 2025 · 0 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #57 · Practice › Storage & stability · 27 Sep 2025 · 12 likes This follows post #54 rather than contradicting it. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #36 · Compounds › Oral incretins · 8 Sep 2025 · 28 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #21 · Evidence › Journal club · 7 Sep 2025 · 15 likes I read post #19 twice before replying, because I had assumed the opposite. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #7 · marked as the solution · Practice › Interactions · 23 Aug 2025 · 27 likes This follows post #4 rather than contradicting it. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid…
-
What a documentation review can and cannot tell you Replied, post #83 · Sourcing › Independent verification · 21 Aug 2025 · 2 likes Picking up post #80: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #27 · Practice › Storage & stability · 14 Aug 2025 · 14 likes Worth separating two things that post #23 runs together. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity…
-
A ten-fold dose error caught before injection — one year on Replied, post #146 · Devices › Syringes & needles · 5 Aug 2025 · 1 like Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
-
About the Administration category Replied, post #8 · Practice › Administration · 31 Jul 2025 · 0 likes I read post #6 twice before replying, because I had assumed the opposite. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #21 · Compounds › Secretagogues & GH axis · 29 Jul 2025 · 27 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #90 · Practice › Storage & stability · 18 Jul 2025 · 8 likes post #89 is right about the mechanism and I think understates the practical bit. Temperature excursions: if a vial sat at room temperature for a time, the question is…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #61 · Compounds › Semaglutide · 9 Jul 2025 · 25 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #70 · Compounds › Other compounds · 24 Jun 2025 · 31 likes post #69 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Pre-registering a personal experiment, seriously Replied, post #56 · Research Methods › N-of-1 designs · 30 May 2025 · 31 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Official shortage notices and what they authorise Replied, post #16 · Access › Shortages · 28 May 2025 · 11 likes Worth separating two things that post #12 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Carryover and the ghost peak from last week's standard Replied, post #70 · Analytics › HPLC & UHPLC · 10 Apr 2025 · 0 likes On post #66 — agreed on the reasoning, with one qualification. Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #88 · Access › International · 9 Mar 2025 · 2 likes I read post #86 twice before replying, because I had assumed the opposite. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed…
-
Validating a method you did not develop — does this still hold? Replied, post #50 · Analytics › Method validation · 27 Feb 2025 · 8 likes Picking up post #47: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #9 · Compounds › Retatrutide · 27 Jan 2025 · 25 likes post #8 answers the question as asked. The question underneath it is different. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
-
Protein density versus volume when you cannot eat much Replied, post #24 · Nutrition & Training › Protein & intake · 27 Jan 2025 · 16 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #7 · Meta › Wiki maintenance · 22 Jan 2025 · 15 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] New subcategory: rationale and scope Replied, post #163 · Meta › Announcements · 19 Jan 2025 · 0 likes Picking up post #160: that is the part I would want checked first. Implementation timeline: announcements include when a change takes effect. Marking the date helps you…
-
Criticising the method without criticising the authors Replied, post #32 · Evidence › Study critique · 17 Jan 2025 · 7 likes Coming back to post #30, because the follow-up matters more than the original answer. Criticise the method, not the author: a paper with a weak design is not a bad…
-
Coming back to: When to suspect the method rather than the sample Replied, post #121 · Analytics › Method validation · 23 Dec 2024 · 1 like Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Building a sensible monitoring schedule with your prescriber Replied, post #95 · Clinical › Bloodwork · 22 Dec 2024 · 0 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
Building a sensible monitoring schedule with your prescriber Replied, post #74 · Clinical › Bloodwork · 21 Dec 2024 · 13 likes I read post #72 twice before replying, because I had assumed the opposite. Analytical imprecision: any measurement has an error margin. A small difference in…
-
Body image changing more slowly than the body Replied, post #12 · Wellbeing › Mental health · 11 Dec 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #3 · Practice › Dosing & titration · 8 Dec 2024 · 7 likes This follows post #2 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #18 · Evidence › Journal club · 24 Nov 2024 · 17 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Gallbladder disease risk with rapid weight loss Replied, post #33 · Clinical › Comorbidities · 20 Nov 2024 · 0 likes Coming back to post #31, because the follow-up matters more than the original answer. Chronic kidney disease: compounds in this class have renal benefit in people with…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #38 · Clinical › Prescriber conversations · 7 Nov 2024 · 0 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
Time to steady state after a dose increase Replied, post #151 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes post #150 is right about the mechanism and I think understates the practical bit. Renal clearance: these compounds are cleared partly via the kidney. In severe renal…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #39 · Clinical › Comorbidities · 15 Oct 2024 · 12 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Irish differences from the UK position Replied, post #26 · Regional › UK & Ireland · 7 Oct 2024 · 24 likes I read post #24 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #30 · Nutrition & Training › Hydration & electrolytes · 7 Aug 2024 · 20 likes Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain sodium balance. Very low sodium intake on these compounds raises…